VNDA R&D Expenses
Vanda Pharmaceuticals Inc · R&D Expenses
VNDA R&D Expenses
Latest reported$36.95Mperiod ending
VNDA Quarterly R&D Expenses ($3.88M → $36.95M)
Quarterly R&D Expenses
High-resolution chart · PNG
VNDA r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 36,953,000 | |
| 28,435,000 | |
| 29,006,000 | |
| 22,563,000 | |
| 21,990,000 | |
| 35,712,000 | |
| 19,840,000 | |
| 16,776,000 | |
| 16,661,000 | |
| 21,154,000 | |
| 24,339,000 | |
| 16,600,000 | |
| 16,647,000 | |
| 19,237,000 | |
| 18,454,000 | |
| 24,857,000 | |
| 21,490,000 | |
| 20,969,000 | |
| 19,331,000 | |
| 19,653,000 | |
| 20,248,000 | |
| 16,131,000 | |
| 14,849,000 | |
| 12,298,000 | |
| 12,903,000 | |
| 15,527,000 | |
| 13,074,000 | |
| 11,347,000 | |
| 10,950,000 | |
| 13,278,000 | |
| 12,922,000 | |
| 11,390,000 | |
| 9,866,000 | |
| 9,416,000 | |
| 10,154,000 | |
| 10,178,000 | |
| 7,648,000 | |
| 10,567,000 | |
| 7,614,000 | |
| 7,294,000 | |
| 6,700,000 | |
| 7,548,000 | |
| 8,747,000 | |
| 9,974,000 | |
| 5,946,000 | |
| 4,478,000 | |
| 4,752,000 | |
| 3,701,000 | |
| 3,514,000 | |
| 7,263,000 | |
| 6,222,000 | |
| 8,026,000 | |
| 5,982,000 | |
| 7,960,000 | |
| 10,617,000 | |
| 10,159,000 | |
| 12,490,000 | |
| 12,180,000 | |
| 10,556,000 | |
| 8,174,000 | |
| 5,999,000 | |
| 4,267,000 | |
| 3,821,618 | |
| 4,072,189 | |
| 2,403,545 | |
| 2,040,647 | |
| 2,253,043 | |
| 2,091,984 | |
| 7,195,595 | |
| 2,333,344 | |
| 3,559,543 | |
| 3,792,424 | |
| 5,480,909 | |
| 11,102,665 | |
| 12,574,735 | |
| 13,874,248 | |
| 10,193,825 | |
| 10,592,059 | |
| 7,939,988 | |
| 9,542,385 | |
| 19,099,850 | |
| 15,488,554 | |
| 5,249,050 | |
| 4,092,240 | |
| 3,671,523 | |
| 3,877,802 |